chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The day after I received the second booster, July 15th, I noticed I was short of breath and my chest got really tight.  This feeling has continued  up until today, August 4th.  There is no way to determine if the cause is from allergies.  I just know the only thing different is that I got the booster.  Sometimes during this time it is really difficult to get air.  In the past when I have an allergic reaction I have lung spasms but I have not had any lung spasms since the boosters.  I also feel really bloated and it causes more difficulty breathing.  I am not sure if this is due to the booster or to my GURD or Asthma. At the clinic the doctor did not find any phlegm.  I was given a nebulizer to help.
Workup significant for sepsis (sirs criteria met with fever T-max 103.1°, HR 103), due to acute UTI, COVID-19 infection, patient is status post 1 L sepsis fluids -normal oxygen saturation on room air on admission -will initiate Rocephin for acute UTI and obtain urine culture, blood cultures  -hold off on remdesivir as patient is not hypoxic.
1ST VACCINE 03/15.  2ND VACCINE 04/9 04/12 - EXTREMELY HEAVY BLEEDING WITH CLOTS WITH MENSTRUAL CYCLE FOR 2 WEEKS 05/9 - HEAVY BLEEDING WITH CLOTS WITH MESTRUAL CYCLE UP TO CURRENT DATE.
This spontaneous report was received from a the patient's daughter, who was also a nursing student, and refers to a 66-year-old female patient. The patient's concurrent conditions included hypertension, hypolipidaemia, osteoarthritis, and heartburn. The patient reacted to metformin. The patient's medical history included gallbladder removal, anxiety, and squamous cell carcinoma on face. On 30-APR-2017, the patient was vaccinated with ZOSTAVAX, one shot once (dose, route of administration, lot # and expiration date were not reported) to prevent shingles. Concomitant therapies included oxybutynin, lisinopril (+) hydrochlorothiazide (manufacturer unknown, reported as lisinopril with HCPV), acyclovir (reported as acyclovir PRN), gabapentin, pravastatin, insulin, LEVEMIR, glimepiride, loratadine (manufacturer unknown), baby aspirin (manufacturer unknown), docusate, calcium (+) vitamin D, citalopram, omeprazole and medication reported as CYCLOVIN. On 07-MAY-2017 (reported as one week after getting ZOSTAVAX), the patient developed the first case of shingles. The patient was treated with acyclovir. When one instance of shingles resolved, it re-occurred in one of two locations: on the patient's middle finger or the lower back (unspecified dates). The patient got shingles 7 times. The patient sought medical attention by seeing a doctor. Unspecified tests were performed to help doctors verify if the patient developed shingles. The outcome of herpes zoster was reported as not recovered/not resolved. The relatedness between the event and ZOSTAVAX was not reported.
Pt reported to ER c/o wheezing, fever and erythema/swelling of L upper extremity. Pt seen in ER 11/5/02. Admitted to inpatient medical unit for IV normal saline, Rocephin, Levaquin, Benadryl, Tylenol and Solu-Medrol. Annual follow up on 02/04/04: "It is unknown if the pt recovered from the adverse events.  We have ad no further communication with this pt. Discharge summary states dyspnea, pneumonia, wheezing, anxiety, increased drug effect, weak, chest pain. msv
Administered 12-26-07; rash 1-6-08; large welts, joint pain, stiffness, lethargy, fever, etc. follow 1 week after rash.
Pt states 3-13 she had redness of injection site. The next day 3-14 she had low grade fever, chills, and the redness of injection site increased size. Injection site was also warm. She went to urgent care and was given antibiotic to treat cellulitis.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), CHILLS (Chills) and MYALGIA (Body Aches) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     The patient's past medical history included Vertigo. Concurrent medical conditions included Cancer, Drug allergy (Amoxicillin) and Drug allergy (Simezax). Concomitant products included CARFILZOMIB (KYPROLIS) for Cancer, POTASSIUM, CALCIUM, COLECALCIFEROL (VIT D [COLECALCIFEROL]) and VENETOCLAX (VENCLEXTA) for an unknown indication.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore), CHILLS (Chills) and MYALGIA (Body Aches). At the time of the report, PAIN IN EXTREMITY (Arm was sore), CHILLS (Chills) and MYALGIA (Body Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Description: The patient received the first dose of the vaccine on 22 Feb 2021 in the left arm. After receiving it, the patient experienced chills, body aches and the arm was sore.   This case was linked to MOD-2021-049921 (Patient Link).
Four patients were administered doses of the Moderna COVID-19 vaccine from an expired vial.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Four patients were administered doses of the Moderna COVID-19 vaccine from an expired vial.) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 051C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Four patients were administered doses of the Moderna COVID-19 vaccine from an expired vial.). On 12-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Four patients were administered doses of the Moderna COVID-19 vaccine from an expired vial.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned.  No treatment details were reported.   Most recent FOLLOW-UP information incorporated above includes: On 28-Jul-2021: Follow up received contains updated patient-1  demographics: Patient initials, age, gender, race and ethinicity; Updated anatomical site of vaccination; On 28-Jul-2021: Follow up received contains updated patient -2 demographics: Patient initials, age, gender, race and ethinicity; Updated anatomical site of vaccination; On 28-Jul-2021: Follow up received contains no new information (NNI) On 28-Jul-2021: Follow up received contains no new information (NNI)
Fever of 102-104 approximately 12hrs after. Ibuprofen/TYLENOL for relief.
sore arm; This case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication.  The patient had a sore arm for about a week after 1st Shingrix shot.
TREMBLING, SPASMS, SHAKING UNCONTROLLABLY, CHILLS, LOSS OF SPEECH MUSCLE FUNCTIONS SUBSQUENT HALLUCINATIONS AND INABILITY TO STAND OR MOVE.
Expired vaccine used; Product administration error; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error). On 08-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and PRODUCT ADMINISTRATION ERROR (Product administration error) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Nov-2021: Follow up received contains reporter details and dose number as booster dose.
injection site pain, tenderness, redness, swelling- hot to the touch. started within 3 hours. Applied ice. Headache- starting 4 hours after the vaccine. relief with tylenol but reappeared after 3-4 hours.  muscle aches/fatigue- about 6 hours after the vaccine. night of the vaccine- muscle aches, fatigue, headache- took tylenol Wednesday-morning of day after vaccine- terrible headache, arm swelling redness and hot to touch, could not lift or touch arm. Extreme fatigue, could not keep my eyes open.  Wednesday night-fever- started around 4pm  tmax 101.0- fevers continued through the night with headache, chills and lower back pain. Extreme fatigue- went to bed around 8pm and woke up at 12pm thursday. Thursday morning- fatigue, increase in swelling and arm tenderness- injection site continued to be very hot to the touch and painful/red.  Applied ice to site. Had a low grade fever 100.6 for a few hours. Tylenol taken ATC.  Thursday night- no fever, headaches or fatigue but injection site cont'd to be red hot and swollen- cellutlits looking  saw my PCP (wednesday prior to fever) who agreed it was a localized reaction with adverse events. Discussed with my physician at work  on thursday night who stated it was a cellulitic localized reaction.  fri morning- injection site improving- remains swollen, slightly itchy. less red and less warm to the touch. Beginning to form a bruise.
They proceed to take the round and at that moment they realize that she was not breathing, she was already compromised . He dies of heart failure.
Symptoms came on suddenly and have lasted through the night and still going the following day. I would like to add that the side effects seem to have targeted areas that were hurting/ailments prior to the vaccine. 1. Headache 2. Fever 101.4 throughout the night 3. Flu like symptoms (felt like I was hit by a truck) 4. Shot was in left arm, however, no real pain. I have trigger finger in my left thumb that was going away, however, the pain intensified through the night. 5. I have Tennis Elbow and Trigger finger in my right thumb that was also starting to go away, but during the night, the pain was intense. 6. I have cuts on the bottom of my feet. During the night, my feet were on fire! I was having to cool them periodically. 7. Massive strange dream.
Itchy near injection site. Mild fever at site. Skin tight at site and mild rash is developing.  Does not hurt but is sensitive. Treated site with cortisone  10 OTC.
Very early menstruation, occurring a couple of hours after the vaccine. It started as spotting that night, (I never spot) then a gradually heavier flow, working up to an unusually heavy & painful period over the course of the next 2 days. Also some very light clotting, which rarely happens for me. I was not due for my period for 2.5 weeks. My cycle is extremely regular and has never deviated from 28-31 days in the last 6+ years. I have a copper IUD (for 6 years), and have never been pregnant.
circular rash m/spot at the site; pain to the site; excruciating pain to the entire left arm and neck; excruciating pain to the entire left arm and neck; This is a spontaneous report received from a contactable nurse. A 40-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no. EN6198) via an unspecified route of administration in the left arm on 06Mar2021 at 09 15, as a single dose for COVID-19 immunisation. Medical history included asthma and migraines. Concomitant medications included TYLENOL, SYMBICORT, albuterol (UNKNOWN MANUFACTURER UNKNOWN), ZYRTEC taken within 2 weeks of vaccination. The patient had allergies to aspirin and NSAIDS. Prior to vaccination, patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested positive for COVID- 19. On 17Mar2021, the patient experienced pain at site and excruciating pain in the entire left arm and neck, also noticed a circular rash m/spot at the site on 18Mar2021 which got larger on 19Mar2021. The clinical outcome of vaccination site pain, vaccination site rash, excruciating pain to the entire left arm and neck was not recovered.   No follow-up attempts are needed. No further information is expected
This case was reported by a lawyer and described the occurrence of joint pain in a male subject of unspecified age who was vaccinated with LYMERIX. A physician or other health care professional has not verified this report. On an unspecified date the subject received unspecified dose of LYMERIX (unknown). At an unspecified time after vaccination with LYMERIX, the subject experienced pain and swelling in his joints, flu-like symptoms, fatigue, headaches, short term memory loss, cognitive problems, back pain, neck pain, shoulder pain, decreased activities of daily life, rheumatologic, neurologic and/or cognitive impairment of an autoimmune, immune-mediated, or other mechanism, all reportedly caused by vaccination with LYMERIX. At the time of reporting the outcome of the events was unspecified. This information was received via a Statement of Injuries. Follow up information was received on 10 December 2008 via an interview between the subject and attorney(s). The subject had a history of fatigue and depression. The subject was vaccinated with LYMERIX on 07 April 1999, 04 May 1999, and 02 June 1999. In the summer of 1999 the subject developed achy joints (upper back, shoulders, ankles, knees). In the winter of 2000 he developed depression and cognitive problems. Cognitive problems were described as "forgetfulness, brain fog, slow processing speed, memory problems, word searching, and disorganization". In 2000 or 2001 he experienced sleep disturbance and testing reportedly confirmed sleep apnea. In 2001 he developed fatigue and severe headaches. Diagnostic tests reportedly showed a "small aneurysm" in the brain, and the subject was advised that the aneurysm was "nothing to worry about". In 2002 he developed stomach problems which "caused weight gain, weight loss, and diarrhea". In 2004 he experienced temper/anger issues and noted that he had quit his previous three jobs after he "blew up at work". In November 2008 he developed hand pain (unable to grip or shake hands without pain). Treatment including a breathing machine, NEXIUM, ROCEPHIN (to treat Lyme disease), unspecified stimulants, and other unspecified medications. With the exception of stomach issues, the events were unresolved at the time of this report. Based upon follow up information, this case was assessed by GSK to be medically significant.
itchy rash on chest and abdomen; This is a spontaneous report from a contactable other healthcare professional (patient). A 67-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in left arm on 03Mar2021 16:30 (Lot Number: EN6305) (at the age of 67-years-old) as dose 1, single for covid-19 immunisation. Medical history included heart ventricle fibrillation. The patient had no known allergies. Concomitant medications included atorvastatin; carvedilol; aspirin; all taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccine within four weeks of vaccination. The patient did not have Covid prior vaccination and was not tested for Covid post vaccination. On 03Mar2021 22:00, the patient experienced itchy rash on chest and abdomen. The patient did not receive any treatment for the event. The outcome of the event was not recovered.   No follow-up attempts are possible. No further information is expected.
4-5" erythematous rash around inj site;warm to touch;no induration;t99.2;
Moderna EUA;  moderate swelling and itching and pain lifting arm at injection site occured 7 days after injection. This swelling and pain is more severe than the initial reaction I had in the three days following the injection.
Vomit blood; Darkening of lips; Eye irritation; HIgh fever with maximum 39.6°C Fever; This spontaneous case was reported by a consumer and describes the occurrence of HAEMATEMESIS (Vomit blood) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HAEMATEMESIS (Vomit blood) (seriousness criterion medically significant), SKIN DISCOLOURATION (Darkening of lips), EYE IRRITATION (Eye irritation) and PYREXIA (HIgh fever with maximum 39.6°C Fever). At the time of the report, HAEMATEMESIS (Vomit blood), SKIN DISCOLOURATION (Darkening of lips), EYE IRRITATION (Eye irritation) and PYREXIA (HIgh fever with maximum 39.6°C Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.  Very limited information regarding these events has been provided at this time.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding these events has been provided at this time.
5 minutes after shot my nose, upper lip and tongue went completely numb.  within 15 minutes after that i got a horrible headache.  It then progressed through the night with horrible body aches and a fever that is ranging between 100 & 101.  I still have all of these symptoms and I feel horrible.
Pt. self identified panic attack post second pfizer vaccine. PT declined RN interventions, self managed symptoms. Pt. ambulated from clinic after describing improved symptoms
I first started feeling symptoms early the next day (10/26/2021) at 2:00 AM after receiving my booster shot.  I experienced injection site pain, headache, and body aches.  The headache and injection site pain subsided after two days.  The body aches continued off and on until my regularly scheduled doctor's appointment on 11/12/2021.  I kept getting upper back pain near my shoulder blade and some head pressure.  During my Dr. Office visit, I found out my blood pressure was extremely elevated approximately 146/88.  My blood pressure had never been that high.  My doctor recommended medication, but I wanted to work on my health on my own for month prior to being medicated.  I did take my doctor's advise and purchased a home BP monitor to keep track of my blood pressure.  Throughout the weekend my blood pressure remained high and my pulse rate was in the high 90s to low 100s.  I contacted my doctor and he prescribed AMLODIPINE 5MG.  I don't know if my high blood pressure and body aches is directly related to the Moderna Booster vaccine, but I suspect it is.
Got the vaccine around 2 p.m. Monday. By 9 a.m. Tuesday, I felt exhausted, which I anticipated. I did not anticipate almost fainting by 1 p.m. and uncontrollable shakes. I was holding a glass of water and almost spilled it on the floor. I could barely keep it steady. It felt like my head was convulsing.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and unknown gender. On an unspecified date, the unspecified number of patients were vaccinated with (Oka/Merck) VARIVAX (lot # L004653 and expiry date: 11-FEB-2017, dose and frequency were unknown), that were improperly stored. No adverse effects were reported. This is one of the several reports from the same reporter. Additional information has been requested.
Heart Palpitations-heart racing on and off; Felt uncomfortable; Felt quite alert and jittery at the same time; Shortening of breath; She wakes up at night; Fatigued; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PALPITATIONS (Heart Palpitations-heart racing on and off), DISCOMFORT (Felt uncomfortable), FEELING JITTERY (Felt quite alert and jittery at the same time), DYSPNOEA (Shortening of breath) and POOR QUALITY SLEEP (She wakes up at night) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PALPITATIONS (Heart Palpitations-heart racing on and off), DISCOMFORT (Felt uncomfortable), FEELING JITTERY (Felt quite alert and jittery at the same time), DYSPNOEA (Shortening of breath), POOR QUALITY SLEEP (She wakes up at night) and FATIGUE (Fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PALPITATIONS (Heart Palpitations-heart racing on and off), DISCOMFORT (Felt uncomfortable), FEELING JITTERY (Felt quite alert and jittery at the same time), DYSPNOEA (Shortening of breath), POOR QUALITY SLEEP (She wakes up at night) and FATIGUE (Fatigued) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications were not provided.  Treatment information was provided included 325mg Tylenol and lots of water.
Pt called hospital call center to c/o of right arm pain after vaccination x2 days. Denies any other symptoms. Reports having some limited range of motion of right should. Has had some relief with ibuprofen.
Fainted; A spontaneous report was received from a 21-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fainted (syncope).    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  The patient received her first of two planned doses of mRNA-1273 (lot/batch number unknown) in the left arm in approximately January 2021 for prophylaxis of COVID-19 infection.  In approximately January 2021 (a few days later after vaccination), the patient experienced fainted.  Treatment information was not provided.  The action taken with mRNA-in response to the event was unknown.  The outcome of the event fainted was unknown.; Reporter's Comments: This case concerns a 21-year-old, female, patient, who experienced a serious unexpected event of syncope. The event occurred at unknown date, reported as few days later, after first dose of mRNA-1273, lot # unknown. Treatment information is not provided. Based on the current available information and temporal association between the use of the product and onset of the event a causal relationship cannot be excluded.
fibrocystic lump that did not go away. he thought ut will go away but started paining  for last 2 weeks
Patient given dose @ 6:00 pm, mother stated prior  that she had passed out with HPV vaccine in past. Had patient lay back while giving vaccine and after 5 minutes she stated she felt fine and proceeded to waiting area. After sitting in chair in waiting room, patient fainted, return to previous state by 6:20.